(1R,3R,5R)-2-Azabicyclo[3.1.0]hexane-3-carboxamide 2,2,2-trifluoroacetate

(1R,3R,5R)-2-Azabicyclo[3.1.0]hexane-3-carboxamide 2,2,2-trifluoroacetate Suppliers list
Company Name: Nanjing XiZe Biotechnology CO., Ltd.  
Tel: 025-66023220 15250997978
Email: 1511893459@qq.com
Company Name: Cato Research Chemicals Inc.  
Tel: +86-020-81960175-877 4000-868-328;4000-868-328
Email: tianwen.zhan@cato-chem.com
Company Name: Meng Cheng Technology (Shanghai) Co., LTD  
Tel: 400-820-6829
Email: sales@mitachieve.com
Company Name: Hubei Xinyang Medical Technology Co., Ltd  
Tel: 15347293736
Email: 2853117764@yongstandards.com
Company Name: Shanghai Zerui Biotechnology Co., Ltd.  
Tel: 021-54580889 18321124657
Email: 1054713992@qq.com
(1R,3R,5R)-2-Azabicyclo[3.1.0]hexane-3-carboxamide 2,2,2-trifluoroacetate Basic information
Product Name:(1R,3R,5R)-2-Azabicyclo[3.1.0]hexane-3-carboxamide 2,2,2-trifluoroacetate
Synonyms:(1R,3R,5R)-2-Azabicyclo[3.1.0]hexane-3-carboxamide 2,2,2-trifluoroacetate;(1R,3R,5R)-2-Azabicyclo[3.1.0]hexane-3-carboxamide 2,2,2-trifluoroacetic Acid;Saxagliptin Impurity 26 Trifluoroacetate;(1R,3R,5R)-2-AXABICYCLO[3.1.0]HEXANE-3-CARBOXAMID TRIFLUORO ACETIC ACID SALT
CAS:1133811-50-3
MF:C8H11F3N2O3
MW:240.1797496
EINECS:
Product Categories:
Mol File:1133811-50-3.mol
(1R,3R,5R)-2-Azabicyclo[3.1.0]hexane-3-carboxamide 2,2,2-trifluoroacetate Structure
(1R,3R,5R)-2-Azabicyclo[3.1.0]hexane-3-carboxamide 2,2,2-trifluoroacetate Chemical Properties
Safety Information
MSDS Information
(1R,3R,5R)-2-Azabicyclo[3.1.0]hexane-3-carboxamide 2,2,2-trifluoroacetate Usage And Synthesis
Uses(1R,3R,5R)-2-Azabicyclo[3.1.0]hexane-3-carboxamide 2,2,2-trifluoroacetic Acid is a reagent in the preparation of methanoprolinenitrile-containing dipeptide mimetics as DPP-IV inhibitors and as antidiabetic agents.
(1R,3R,5R)-2-Azabicyclo[3.1.0]hexane-3-carboxamide 2,2,2-trifluoroacetate Preparation Products And Raw materials
Tag:(1R,3R,5R)-2-Azabicyclo[3.1.0]hexane-3-carboxamide 2,2,2-trifluoroacetate(1133811-50-3) Related Product Information
1H-Cyclopropa[4,5]pyrrolo[1,2-a]pyrazine-3,6-dione, hexahydro-4-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-, (1aS,4S,6aR,7aS)- 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3S,5S)- 3-Hydroxy-1-AdaMantane Carboxylic Acid Tricyclo[3.3.1.13,7]decane-1-acetic acid, α-[[(1,1-diMethylethoxy)carbonyl]aMino]-3,5-dihydroxy-, (αS)- 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3S,5R)- Saxagliptin Impurity 34 (1R,3S,5R)-2-Azabicyclo[3.1.0]hexane-3-carboxamide 2,2,2-trifluoroacetic acid Saxagliptin Impurity 16 1H-Pyrrole-1-carboxylic acid, 2-(aMinocarbonyl)-2,3-dihydro-, 1,1-diMethylethyl ester, (2S)- Hydroxy Saxagliptin (S) - N- Boc- adamantylglycine (R)-N-Boc-3-hydroxyadaMantylglycine 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3R,5S)- 3H-Cyclopropa[4,5]pyrrolo[1,2-a]pyrazin-3-one, 6-aMino-1,1a,4,6a,7,7a-hexahydro-4-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-, (1aS,4S,6aR,7aS)- 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3S,5R)- Saxagliptin 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)- (1S,3S,5S)-2-(tert-Butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid